These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25163639)
1. A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics. Topcuoglu S; Gursoy T; Ovalı F; Serce O; Karatekin G J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1491-4. PubMed ID: 25163639 [TBL] [Abstract][Full Text] [Related]
2. Tolerability of a probiotic in subjects with a history of methicillin-resistant Staphylococcus aureus colonisation. Warrack S; Panjikar P; Duster M; Safdar N Benef Microbes; 2014 Dec; 5(4):389-95. PubMed ID: 25213147 [TBL] [Abstract][Full Text] [Related]
3. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci. Crouzet L; Rigottier-Gois L; Serror P FEMS Microbiol Lett; 2015 Apr; 362(8):fnv012. PubMed ID: 25667231 [TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Flokas ME; Karageorgos SA; Detsis M; Alevizakos M; Mylonakis E Int J Antimicrob Agents; 2017 May; 49(5):565-572. PubMed ID: 28336313 [TBL] [Abstract][Full Text] [Related]
5. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455 [TBL] [Abstract][Full Text] [Related]
6. A new use of Buyukeren M; Yigit S; Buyukcam A; Kara A; Celik HT; Yurdakok M J Matern Fetal Neonatal Med; 2022 Mar; 35(6):1192-1198. PubMed ID: 32208789 [TBL] [Abstract][Full Text] [Related]
7. Routine Use of Probiotics in Preterm Infants: Longitudinal Impact on the Microbiome and Metabolome. Abdulkadir B; Nelson A; Skeath T; Marrs EC; Perry JD; Cummings SP; Embleton ND; Berrington JE; Stewart CJ Neonatology; 2016; 109(4):239-47. PubMed ID: 26859305 [TBL] [Abstract][Full Text] [Related]
8. Lactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococci. Li M; Lee K; Hsu M; Nau G; Mylonakis E; Ramratnam B BMC Microbiol; 2017 Mar; 17(1):66. PubMed ID: 28288575 [TBL] [Abstract][Full Text] [Related]
9. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Bonten MJ; Hayden MK; Nathan C; van Voorhis J; Matushek M; Slaughter S; Rice T; Weinstein RA Lancet; 1996 Dec; 348(9042):1615-9. PubMed ID: 8961991 [TBL] [Abstract][Full Text] [Related]
11. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178 [TBL] [Abstract][Full Text] [Related]
12. [Vancomycin-resistant enterococcus colonization in neonatal intensive care unit: prevention and eradication experience]. Benzer D; Yavuzcan Öztürk D; Gürsoy T; Ocalmaz MS; Karatekin G; Ovalı HF Mikrobiyol Bul; 2012 Oct; 46(4):682-8. PubMed ID: 23188582 [TBL] [Abstract][Full Text] [Related]
13. Effect of probiotics on multi-resistant organism colonisation in persons with spinal cord injury: secondary outcome of ProSCIUTTU, a randomised placebo-controlled trial. Toh SL; Lee BB; Simpson JM; Rice SA; Kotsiou G; Marial O; Ryan S Spinal Cord; 2020 Jul; 58(7):755-767. PubMed ID: 31953482 [TBL] [Abstract][Full Text] [Related]
14. Elimination of vancomycin-resistant enterococci from a neonatal intensive care unit following an outbreak. Ergaz Z; Arad I; Bar-Oz B; Peleg O; Benenson S; Minster N; Moses A; Block C J Hosp Infect; 2010 Apr; 74(4):370-6. PubMed ID: 19932526 [TBL] [Abstract][Full Text] [Related]
15. Vancomycin-resistant enterococci: why are they here, and where do they come from? Bonten MJ; Willems R; Weinstein RA Lancet Infect Dis; 2001 Dec; 1(5):314-25. PubMed ID: 11871804 [TBL] [Abstract][Full Text] [Related]
16. Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities. Doron S; Hibberd PL; Goldin B; Thorpe C; McDermott L; Snydman DR Antimicrob Agents Chemother; 2015 Aug; 59(8):4593-9. PubMed ID: 26014940 [TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant Enterococcus outbreak in a neonatal intensive care unit: epidemiology, molecular analysis and risk factors. Iosifidis E; Evdoridou I; Agakidou E; Chochliourou E; Protonotariou E; Karakoula K; Stathis I; Sofianou D; Drossou-Agakidou V; Pournaras S; Roilides E Am J Infect Control; 2013 Oct; 41(10):857-61. PubMed ID: 23669299 [TBL] [Abstract][Full Text] [Related]
18. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. Sikorska H; Smoragiewicz W Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026 [TBL] [Abstract][Full Text] [Related]
19. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection. Miller M; Bernard L; Thompson M; Grima D; Pepin J Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636 [TBL] [Abstract][Full Text] [Related]
20. Comparison of stool colonization in premature infants by three dose regimes of a probiotic combination: a randomized controlled trial. Dutta S; Ray P; Narang A Am J Perinatol; 2015 Jul; 32(8):733-40. PubMed ID: 25519197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]